157 related articles for article (PubMed ID: 37840517)
1. A pocket companion to cell-free DNA (cfDNA) preanalytics.
Bronkhorst AJ; Holdenrieder S
Tumour Biol; 2024; 46(s1):S297-S308. PubMed ID: 37840517
[TBL] [Abstract][Full Text] [Related]
2. New Perspectives on the Importance of Cell-Free DNA Biology.
Bronkhorst AJ; Ungerer V; Oberhofer A; Gabriel S; Polatoglou E; Randeu H; Uhlig C; Pfister H; Mayer Z; Holdenrieder S
Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140548
[TBL] [Abstract][Full Text] [Related]
3. Impact of Preanalytical and Analytical Methods on Cell-Free DNA Diagnostics.
Krasic J; Abramovic I; Vrtaric A; Nikolac Gabaj N; Kralik-Oguic S; Katusic Bojanac A; Jezek D; Sincic N
Front Cell Dev Biol; 2021; 9():686149. PubMed ID: 34552921
[TBL] [Abstract][Full Text] [Related]
4. Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms.
Grabuschnig S; Bronkhorst AJ; Holdenrieder S; Rosales Rodriguez I; Schliep KP; Schwendenwein D; Ungerer V; Sensen CW
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137955
[TBL] [Abstract][Full Text] [Related]
5. Potential of modern circulating cell-free DNA diagnostic tools for detection of specific tumour cells in clinical practice.
Gašperšič J; Videtič Paska A
Biochem Med (Zagreb); 2020 Oct; 30(3):030504. PubMed ID: 32774122
[TBL] [Abstract][Full Text] [Related]
6. Blood has never been thicker: Cell-free DNA fragmentomics in the liquid biopsy toolbox of B-cell lymphomas.
Meriranta L; Pitkänen E; Leppä S
Semin Hematol; 2023 Jul; 60(3):132-141. PubMed ID: 37455222
[TBL] [Abstract][Full Text] [Related]
7. SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA.
Kockan C; Hach F; Sarrafi I; Bell RH; McConeghy B; Beja K; Haegert A; Wyatt AW; Volik SV; Chi KN; Collins CC; Sahinalp SC
Bioinformatics; 2017 Jan; 33(1):26-34. PubMed ID: 27531099
[TBL] [Abstract][Full Text] [Related]
8. Bridging biological cfDNA features and machine learning approaches.
Moser T; Kühberger S; Lazzeri I; Vlachos G; Heitzer E
Trends Genet; 2023 Apr; 39(4):285-307. PubMed ID: 36792446
[TBL] [Abstract][Full Text] [Related]
9. The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples.
Peng H; Pan M; Zhou Z; Chen C; Xing X; Cheng S; Zhang S; Zheng H; Qian K
Front Cell Dev Biol; 2024; 12():1385041. PubMed ID: 38784382
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy: current technology and clinical applications.
Nikanjam M; Kato S; Kurzrock R
J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsies based on cell-free DNA as a potential biomarker in head and neck cancer.
Rapado-González Ó; Rodríguez-Ces AM; López-López R; Suárez-Cunqueiro MM
Jpn Dent Sci Rev; 2023 Dec; 59():289-302. PubMed ID: 37680614
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy in colon cancer: comparison of different circulating DNA extraction systems following absolute quantification of
Kloten V; Rüchel N; Brüchle NO; Gasthaus J; Freudenmacher N; Steib F; Mijnes J; Eschenbruch J; Binnebösel M; Knüchel R; Dahl E
Oncotarget; 2017 Oct; 8(49):86253-86263. PubMed ID: 29156792
[TBL] [Abstract][Full Text] [Related]
13. Cell-Free DNA Fragmentomics in Liquid Biopsy.
Ding SC; Lo YMD
Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35454026
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Preanalytical and Physiological Variables on Cell-Free DNA Fragmentation.
van der Pol Y; Moldovan N; Verkuijlen S; Ramaker J; Boers D; Onstenk W; de Rooij J; Bahce I; Pegtel DM; Mouliere F
Clin Chem; 2022 Jun; 68(6):803-813. PubMed ID: 35292813
[TBL] [Abstract][Full Text] [Related]
15. Preanalytical variables that affect the outcome of cell-free DNA measurements.
Ungerer V; Bronkhorst AJ; Holdenrieder S
Crit Rev Clin Lab Sci; 2020 Nov; 57(7):484-507. PubMed ID: 32393081
[TBL] [Abstract][Full Text] [Related]
16. A nano-magnetic size selective cfDNA extraction platform for liquid biopsy with enhanced precision.
Liu Y; Cheng L; Wang G; Lv J; He Y; Shao PL; Hu R; Xiao H; Tang J; Niu D; Yang J; Tang Z; Xu Z; Liu Y; Li Y; Song K; Wu B; Zhang B
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 May; 1199():123236. PubMed ID: 35472714
[TBL] [Abstract][Full Text] [Related]
17. A Study of Pre-Analytical Variables and Optimization of Extraction Method for Circulating Tumor DNA Measurements by Digital Droplet PCR.
Cavallone L; Aldamry M; Lafleur J; Lan C; Gonzalez Ginestet P; Alirezaie N; Ferrario C; Aguilar-Mahecha A; Basik M
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):909-916. PubMed ID: 30824523
[TBL] [Abstract][Full Text] [Related]
18. Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients.
Hallermayr A; Wohlfrom T; Steinke-Lange V; Benet-Pagès A; Scharf F; Heitzer E; Mansmann U; Haberl C; de Wit M; Vogelsang H; Rentsch M; Holinski-Feder E; Pickl JMA
J Hematol Oncol; 2022 Sep; 15(1):125. PubMed ID: 36056434
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy in lymphoma: Molecular methods and clinical applications.
Cirillo M; Craig AFM; Borchmann S; Kurtz DM
Cancer Treat Rev; 2020 Dec; 91():102106. PubMed ID: 33049623
[TBL] [Abstract][Full Text] [Related]
20. Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics.
van Ginkel JH; van den Broek DA; van Kuik J; Linders D; de Weger R; Willems SM; Huibers MMH
Cancer Med; 2017 Oct; 6(10):2297-2307. PubMed ID: 28940814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
